Friday 12 March, 2010This week
10/03/2010 | Once yearly intravenous zolendronate is associated with a higher rate of fractures in patients with osteoporosis compared to treatment with weekly bisphosphonates, a study by a Sydney rheumatologist finds.
10/03/2010 | Obese children as young as 3 years old have been found to have elevated levels of inflammatory markers, particularly CRP.
10/03/2010 | The landmark award of $287,000 compensation to a Melbourne man who had a heart attack in 2003 while taking rofecoxib (Vioxx) was based on the way the drug was promoted as safe to GPs.
News
More news ...